Form 4: Astrana Health Director John Chiang Receives Equity Grant Under 2024 Incentive Plan

Astrana Health, Inc. Director John Chiang was granted 6,449 shares of common stock as part of the company's 2024 Equity Incentive Plan, aligning his interests with shareholders.

Summary

• John Chiang, a Director of Astrana Health, Inc. (ASTH), was granted 6,449 shares of the company's common stock.
• The transaction occurred on June 11, 2025.
• These shares were granted at a price of $0, indicating they are restricted stock awards.
• The grant was made pursuant to the Issuer's 2024 Equity Incentive Plan.
• The restricted shares will vest on the earlier of June 11, 2026, or the date of Astrana Health's 2026 annual meeting of stockholders.
• Following this transaction, John Chiang beneficially owns 23,132 shares of Astrana Health common stock.

Sentiment

Score: 6

Explanation: Slightly positive due to routine director compensation aligning interests, but not significantly impactful on its own.

Positives

• The grant of restricted stock to Director John Chiang aligns his long-term interests with those of Astrana Health shareholders.
• The transaction is part of a pre-existing 2024 Equity Incentive Plan, indicating a structured approach to executive and director compensation.

Future Outlook

The granted restricted shares are scheduled to vest on the earlier of June 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, indicating a future milestone for the compensation.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity grant, common practice across industries for director compensation and alignment. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• The grant of restricted stock to directors is a standard practice in corporate governance across various industries, including healthcare, to align director interests with long-term shareholder value. Specific comparable companies or projects are not detailed in this filing.

Corporate Governance

Related Party Transactions

• The grant of 6,449 shares of common stock to John Chiang, a Director of Astrana Health, Inc., constitutes a related party transaction as it involves a company insider.

Stakeholder Impact

• Shareholders: The equity grant aims to align the director's interests with shareholders, potentially encouraging decisions that enhance long-term stock value.

Next Steps

• Vesting of the 6,449 restricted shares on the earlier of June 11, 2026, or the date of Astrana Health's 2026 annual meeting of stockholders.

Key Dates

Keywords

Astrana Health, ASTH, Form 4, Insider transaction, Equity grant, Restricted stock, Director compensation, Beneficial ownership, Equity Incentive Plan